Clinical Trial Results: Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results assessing efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• CDR132L

Snippet

Sponsor: Cardior Pharmaceuticals GmbH | Conditions: Myocardial Infarction, Acute, Heart Failure, Left Sided | Phase 2 | Status: COMPLETED | Results posted: 2026-08-26